专利号:US-8546532-B2 优先权日:2008-04-17 标题:Synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders 发明人:BONNIN DUSTAN; ZANELLI ERIC; MATHERS THOMAS 权利人:BONNIN DUSTAN; ZANELLI ERIC; MATHERS THOMAS; DECLION PHARMACEUTICALS INC 摘要:The instant invention comprises a process for the solid phase synthesis of directed epitope peptide mixtures useful in the treatment and diagnosis of protein conformational disorders, such process defined by a set of rules regarding the identity and the frequency of occurrence of amino acids that substitute a base or native amino acid of a known epitope. The resulting composition is a mixture of related peptides for therapeutic use. The invention also pertains to the process of generating antibodies using the directed epitope peptide mixtures as the antigens, and antibodies generated by such process, useful in the treatment and diagnostics of the said protein conformational disorder.
专利号:WO-2024165611-A1 优先权日:2023-02-07 标题:Production of a disaccharide and/or milk oligosaccharide by a cell with reduced synthesis of udp-glcnac 发明人:BEAUPREZ JOERI; DECOENE THOMAS; VERCAUTEREN ANNELIES 权利人:INBIOSE NV 摘要:The present invention is in the technical field of synthetic biology, metabolic engineering and cell cultivation. The invention provides a cell for production of a disaccharide and/or an oligosaccharide like a milk oligosaccharide wherein synthesis of UDP-N-acetylglucosamine in said cell is rendered less functional. The invention further provides use of said cell in a cultivation or incubation. The invention also describes methods for the production of a disaccharide and/or an oligosaccharide like a milk oligosaccharide using said cell as well as the purification of said disaccharide and/or oligosaccharide like a milk oligosaccharide.
专利号:US-12264143-B2 优先权日:2020-12-17 标 题:Synthesis of cannabinoids and cannabinoid precursors, and related compounds, formulations, and methods of use 发明人:SAMMIS GLENN M; ROGGEN MARKUS 权利人:NALU BIO INC 摘要:Methods are provided for the synthesis of cannabinoids, including cannabidiol (CBD), cannabinol (CBN), cannabichromene (CBC), cannabidiolic acid (CBDA), cannabigerol (CBG), cannabigerolic acid (CBGA), cannabidivarin (CBDV), cannabidibutol (CBD-C4), dihydrocannabidiol (DCBD), tetrahydrocannabivarin (THCV), analogs thereof, and precursors to the foregoing. One method employs phloroglucinol or a phloroglucinol analog as a starting material. The syntheses are stereospecific, efficient, selective, and cost-effective, with little or no potential for generation of THC ((−)-trans-Δ9-tetrahydro-cannabinol) or any other psychoactive side product. Telescoped syntheses are also provided, as are new cannabinoids, pharmaceutical formulations, and methods of use.
专利号:US-5043328-A 优先权日:1986-05-09 标 题 :Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems 发明人:WEITHMANN KLAUS U 权利人:HOECHST AG 摘要:The present invention relates to formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems and to the use of such formulations for the preparation of medicaments which are suitable for curing prostaglandin deficiencies in humans or animal, for example healing or preventing diseases of the gastro-intestinal tract.
专利号:US-2017283878-A1 优先权日:2015-12-11 标题:Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers 发明人:WONG CHI-HUEY; WU CHUNG-YI; CHEUNG SARAH K C; CHUANG PO-KAI; HSU TSUI-LING 权利人:ACADEMIA SINICA 摘要:The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid SSEA-3/SSEA-4/GloboH in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4GalT; beta-4GalNAcT-I; or beta-3GalT-V enzymes in the globoseries synthetic pathway. Additionally, the present disclosure is also directed to vaccines, antibodies, and/or immunogenic conjugate compositions targeting the SSEA-3/SSEA-4/GLOBO H associated epitopes (natural and modified) which elicit antibodies and/or binding fragment production useful for modulating the globoseries glycosphingolipid synthesis. Moreover, the present disclosure is also directed to the method of using the compositions described herein for the treatment or detection of hyperproliferative diseases and/or conditions. Furthermore, the instant disclosure also relates to cancer stem cell biomarkers for diagnostic and therapeutic uses.
专利号:US-8742013-B2 优先权日:2009-04-24 标 题:Synthesis of lipoamide-grafted high molecular compound and method therefor 发明人:NOH INSUP; JO SEONGYEUN; KIM DOYEON; WOO JUNGHOON 权利人:NOH INSUP; JO SEONGYEUN; KIM DOYEON; WOO JUNGHOON; NAT UNIV SEOUL TECH CTENTER 摘要:The present disclosure provides polymer compounds binding with lipoamide produced by the reaction of the primary amine group of lipoamide with the carboxy group of polysaccharide compounds such as chondroitin sulfates, carboxymethyl celluloses, or hyaluronic acids; functional compounds such as peptides, proteins, growth factors; or drugs; or biocompatible polymers such as poly(ethylene oxide), poly(vinyl alcohol), or poly(vinyl pyrrolidone). The present disclosure also provides their synthesis methods, products of hydrogels and films using the same as and methods for manufacturing the products.
1: Teema AM, Zaitone SA, Moustafa YM. Ibuprofen or piroxicam protects nigral neurons and delays the development of L-dopa induced dyskinesia in rats with experimental Parkinsonism: influence on angiogenesis. Neuropharmacology. 2016 Mar 22. pii: S0028-3908(16)30106-X. doi: 10.1016/j.neuropharm.2016.03.034. [Epub ahead of print] doi: 10.3109/03639045.2015.1054400. Epub 2015 Jun 11. doi: 10.1016/j.jpba.2015.12.042. Epub 2015 Dec 28. doi: 10.4137/CMAMD.S29463. eCollection 2016. 6: Sivaraman A, Banga AK. Formulation and evaluation of sublingual delivery of piroxicam using thermosensitive polymer with an inverted Franz diffusion cell. J Pharm Pharmacol. 2016 Jan;68(1):26-35. doi: 10.1111/jphp.12493. Epub 2015 Dec 29. doi: 10.1016/j.pharep.2015.05.012. Epub 2015 May 30. doi: 10.1111/vco.12059. Epub 2013 Jul 26. doi: 10.1016/j.reuma.2014.12.003. Epub 2015 Jan 28. English, Spanish. doi: 10.1016/j.msec.2015.06.006. Epub 2015 Jun 14. doi: 10.4103/1673-5374.165509. 12: John P, Azeem W, Ashfaq M, Khan IU, Razzaq SN. Stability indicating RP-HPLC method for simultaneous determination of piroxicam and ofloxacin in binary combination. Pak J Pharm Sci. 2015 Sep;28(5):1713-21. doi: 10.1016/j.neuroscience.2015.05.030. Epub 2015 May 18. doi: 10.1002/jps.24421. Epub 2015 Mar 16. doi: 10.1021/mp500872g. Epub 2015 Apr 17. doi: 10.1016/j.saa.2014.11.040. Epub 2014 Nov 28. doi: 10.3109/10837450.2013.860549. Epub 2013 Nov 25. doi: 10.1097/MIB.0000000000000269.
合成参考文献
参考文献:10.1016/j.jpba.2011.06.012 摘要:Modhave DT, Handa T, Shah RP, Singh S. Stress degradation studies on lornoxicam using LC, LC–MS/TOF and LC–MSn. Journal of Pharmaceutical and Biomedical Analysis. 2011 Nov;56(3):538–45. doi: 10.1016/j.jpba.2011.06.012. 参考文献:10.1159/000327658 摘要:Tuzuner Oncul AM, Yazicioglu D, Alanoglu Z, Demiralp S, Ozturk A, Ucok C. Postoperative analgesia in impacted third molar surgery: the role of preoperative diclofenac sodium, paracetamol and lornoxicam. Med Princ Pract. 2011;20(5):470–6. doi: 10.1159/000327658. 参考文献:10.1186/1471-2474-12-165 摘要:Peloso PM, Gammaitoni A, Smugar SS, Wang H, Moore AR. Longitudinal Numbers-Needed-To-Treat (NNT) for Achieving Various Levels of Analgesic Response and Improvement with Etoricoxib, Naproxen, and Placebo in Ankylosing Spondylitis. BMC Musculoskeletal Disorders. 2011 Jul 18;12(1):165. doi: 10.1186/1471-2474-12-165. 参考文献:10.2165/11592550-000000000-00000 摘要:Altman RD, Barthel HR. Topical therapies for osteoarthritis. Drugs. 2011 Jul 09;71(10):1259–79. doi: 10.2165/11592550-000000000-00000. 参考文献:10.1016/j.lfs.2011.06.026 摘要:Nesseem DI, Eid SF, El-Houseny SS. Development of novel transdermal self-adhesive films for tenoxicam, an anti-inflammatory drug. Life Sci. 2011 Sep 26;89(13-14):430–8. doi: 10.1016/j.lfs.2011.06.026.